Life expectancy and cure rate for lobular breast cancer

Contents:

Medical Video: What Is the Difference Between Staging and Grading in Breast Cancer?

Lobular breast cancer, also called invasive lobular carcinoma (ILC), occurs in the breast lobule. Lobules are the breast area that produces milk. ILC is the second most common type of breast cancer, affecting around 10 percent of people with invasive breast cancer. Most people with breast cancer have disease in their ducts (invasive ductal carcinoma (IDC)), which is a structure that carries milk.

The word "invasive" indicates that the cancer has spread to other regions of the origin. In the case of ILC, it has spread to certain breast lobules. For some people, this means cancer cells are present in other parts of the breast tissue. For others, this disease has spread (metastasis) to other parts of the body.

Even though a person can be diagnosed with lobular breast cancer at any age, it is most common in women aged 60 years or older. Research shows that hormone replacement therapy after menopause can increase the risk of this type of cancer.

Prognosis

Like other cancers, the ILC stadium is on a scale of 0-4. Stadium is related to tumor size and spread to other areas of the body. Larger numbers represent stadium development. Higher stages generally have a worse prognosis.

The earlier you are diagnosed with lobular breast cancer and start treatment, the better your prognosis. Like other types of cancer, the early stages of ILC are likely to be more easily treated with fewer complications. Usually - but not always - leads to full recovery and a low relapse rate. However, early diagnosis is a significant challenge to ILC compared to IDC which is far more common. That is because the growth and spread of the ILC pattern is more difficult to detect on routine mammograms and breast examinations.

Your prognosis depends not only on the stage of the cancer, but also on the long-term treatment plan. Follow-up examinations and tests can help doctors detect cancer recurrence or other complications that may arise after breast cancer treatment. Schedule a physical examination and mammogram every year. The first must be done six months after surgery or after radiation therapy.

Life expectancy

Life expectancy for cancer is usually calculated by calculating how many people live at least five years after being diagnosed. Despite having a similar survival rate between ILC and IDC, studies have shown that patients with lobular breast cancer have a slightly better outlook for short-term and long-term survival.

A study published inBritish Journal of Cancer in 1997 showed that people with ILC had a slight spread of cancer and a five and 30 year survival rate was higher than IDC patients. At ILC, the five-year survival rate is 78 percent, and the 30-year survival rate is 50 percent. At IDC, the five-year survival rate is 63 percent, and the 30-year survival rate is 37 percent.

The latest study published in Breast Cancer Research shows a five-year survival rate has increased. This study showed an increase for both types of about 85 percent in lobular carcinoma and about 83 percent in ductal cancer. While the difference between the two types of cancer is not too much in the latest research, the prognosis of lobular cancer still seems brighter than ductal cancer.

Treatment

ILC can be more difficult to diagnose than other forms of breast cancer, because it spreads in a unique branching pattern. The good news is that cancer is relatively slow growing, giving you time to make a treatment plan with your cancer team. There are several treatment options that can help increase your chances of full recovery.

Treatment varies depending on the stage of your cancer. Small tumors in the breast that have not spread can be removed with lumpectomy. This procedure is a low scale version of full mastectomy. In lumpectomy, only part of the breast tissue is removed. In a mastectomy, the entire breast is removed.

Chemotherapy can be used to shrink tumors before surgery. You may need radiation after a lumpectomy to make sure all cancer cells have disappeared.

The doctor will help you create a personalized care plan based on your health, using the latest available technology.

Life is better

The diagnosis of lobular breast cancer can be frightening, especially because it is more difficult to diagnose and not too much studied as ductal cancer, a more common type. However, that is not a death sentence. Many people live long after their diagnosis. Medical research and technology available five years ago may not be as advanced as it is today. The current diagnosis of ILC may have a more positive outlook than five or more years ago.

Life expectancy and cure rate for lobular breast cancer
Rated 5/5 based on 877 reviews
💖 show ads